Prasad V, Sheard M H
Pharmacol Biochem Behav. 1983 Sep;19(3):419-21. doi: 10.1016/0091-3057(83)90112-0.
Changes in shock-elicited fighting (SEF) were measured following single or repeated injections (IP) of dl-propranolol (5 mg/kg, 20 mg/kg) or quipazine (1.25 mg/kg, 2.5 mg/kg) given either alone or in combination to saline or desipramine (DMI) (10 mg/kg) treated rats. DMI + propranolol (20 mg/kg) caused a greater increase in fighting than DMI + saline 18 hours after last dose. Propranolol (20 mg/kg) produced an equal inhibition in both of these groups at 15 min. Propranolol (5 mg/kg) had no effect. Quipazine (2.5 mg/kg) failed to alter DMI induced increase in SEF. The combination of propranolol (5 mg/kg) + quipazine (1.25 mg/kg) blocked the enhanced SEF significantly in DMI treated rats in comparison to DMI + saline treated group. This combination of propranolol + quipazine produced no significant change in SEF in saline treated group in comparison to the pretest level. These results suggested that propranolol + quipazine act synergistically at low doses to inhibit the increased SEF seen in DMI treated rats and might have therapeutic implications for the management of irritable aggression or mania.
在对生理盐水或去甲丙咪嗪(DMI,10mg/kg)处理的大鼠单独或联合腹腔注射(IP)dl-普萘洛尔(5mg/kg、20mg/kg)或喹哌嗪(1.25mg/kg、2.5mg/kg)后,测量休克诱发战斗行为(SEF)的变化。末次给药18小时后,DMI + 普萘洛尔(20mg/kg)组的战斗行为增加幅度大于DMI + 生理盐水组。在15分钟时,普萘洛尔(20mg/kg)对这两组的抑制作用相同。普萘洛尔(5mg/kg)无作用。喹哌嗪(2.5mg/kg)未能改变DMI诱导的SEF增加。与DMI + 生理盐水处理组相比,普萘洛尔(5mg/kg)+喹哌嗪(1.25mg/kg)联合用药显著阻断了DMI处理大鼠增强的SEF。与预测试水平相比,普萘洛尔 + 喹哌嗪联合用药在生理盐水处理组的SEF中未产生显著变化。这些结果表明,普萘洛尔 + 喹哌嗪在低剂量下协同作用,抑制DMI处理大鼠中观察到的SEF增加,可能对易怒性攻击或躁狂的管理具有治疗意义。